Abstract
S1093 A Comparison of Weight Gain Profiles of Tumor Necrosis Factor (TNF)-Alpha Inhibitors, Ustekinumab, and Vedolizumab in the Treatment of Patients With Inflammatory Bowel Disease (IBD)
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
